Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 289

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

Open access
Arbelaiz, Ander, Azkargorta, Mikel, Krawczyk, Marcin, Santos‐Laso, Alvaro, Lapitz, Ainhoa, Perugorria, Maria J., Erice, Oihane, Gonzalez, Esperanza, Jimenez‐Agüero, Raul, Lacasta, Adelaida, Ibarra, Cesar, Sanchez‐Campos, Alberto, Jimeno, Juan P., Lammert, Frank, Milkiewicz, Piotr, Marzioni, Marco, Macias, Rocio I.R., Marin, Jose J.G., Patel, Tushar, Gores, Gregory J., Martinez, Ibon, Elortza, Félix, Falcon‐Perez, Juan M., Bujanda, Luis, Banales, Jesus M.·2017·Hepatology

Abstract

Cholangiocarcinoma (CCA) includes a heterogeneous group of biliary cancers with poor prognosis. Several conditions, such as primary sclerosing cholangitis (PSC), are risk factors. Noninvasive differential diagnosis between intrahepatic CCA and hepatocellular carcinoma (HCC) is sometimes difficult. Accurate noninvasive biomarkers for PSC, CCA, and HCC are not available. In the search for novel biomarkers, serum extracellular vesicles (EV) were isolated from CCA (n = 43), PSC (n = 30), or HCC (n = 29) patients and healthy individuals (control, n = 32); and their protein content was characterized. By using nanoparticle tracking analysis, serum EV concentration was found to be higher in HCC than in all the other groups. Round morphology (by transmission electron microscopy), size (∼180 nm diameter by nanoparticle tracking analysis), and markers (clusters of differentiation 9, 63, and 81 by immunoblot) indicated that most serum EV were exosomes. Proteome profiles (by mass spectrometry) revealed multiple differentially expressed proteins among groups. Several of these proteins showed high diagnostic values with maximum area under the receiver operating characteristic curve of 0.878 for CCA versus control, 0.905 for CCA stage I‐II versus control, 0.789 for PSC versus control, 0.806 for noncirhottic PSC versus control, 0.796 for CCA versus PSC, 0.956 for CCA stage I‐II versus PSC, 0.904 for HCC versus control, and 0.894 for intrahepatic CCA versus HCC. Proteomic analysis of EV derived from CCA human cells in vitro revealed higher abundance of oncogenic proteins compared to EV released by normal human cholangiocytes. Orthotopic implant of CCA human cells in the liver of immunodeficient mice resulted in the release to serum of EV containing some similar human oncogenic proteins. Conclusion: Proteomic signatures found in serum EV of CCA, PSC, and HCC patients show potential usefulness as diagnostic tools. (H epatology 2017;66:1125‐1143).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.29291

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 289

Metadata

Authors
Arbelaiz, A., Azkargorta, M., Krawczyk, M., Santos‐Laso, A., Lapitz, A., Perugorria, M. J., Erice, O., Gonzalez, E., Jimenez‐Agüero, R., Lacasta, A., Ibarra, C., Sanchez‐Campos, A., Jimeno, J. P., Lammert, F., Milkiewicz, P., Marzioni, M., Macias, R. I. R., Marin, J. J. G., Patel, T., Gores, G. J., Martinez, I., Elortza, F., Falcon‐Perez, J. M., Bujanda, L., & Banales, J. M.
Venue
Hepatology
Published
2017-08-26
Volume
66
Issue
4
Pages
1125-1143
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W2619076775
Cited by
289
References
40
FWCI
10.00
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma. https://app.cochat.ai/papers/10.1002/hep.29291
The paper
Arbelaiz, A., Azkargorta, M., Krawczyk, M., Santos‐Laso, A., Lapitz, A., Perugorria, M. J., Erice, O., Gonzalez, E., Jimenez‐Agüero, R., Lacasta, A., Ibarra, C., Sanchez‐Campos, A., Jimeno, J. P., Lammert, F., Milkiewicz, P., Marzioni, M., Macias, R. I. R., Marin, J. J. G., Patel, T., . . . Banales, J. M. (2017). Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma. Hepatology. https://doi.org/10.1002/hep.29291

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.